Insider · CIK 0001654539
Justin Dye
Files at SHWZ (Medicine Man Technologies, Inc.). First filing -, latest -.
In brief
Justin Dye files SEC Form 4 as director and 10% owner at SHWZ (Medicine Man Technologies, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Justin Dye has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 29, 2023 | SHWZ Medicine Man Technologies, Inc. | AGrant or award Common Stock | +123,153 | $0.00 | $0 | 1,739,516 | Feb 15, 2024 |
| May 15, 2023 | SHWZ Medicine Man Technologies, Inc. | POpen-market purchase Series A Cumulative Convertible Preferred Stockderivativeindirect: See footnote | +183 | $1,000.00 | $183k | 183 | Feb 15, 2024 |
| May 15, 2023 | SHWZ Medicine Man Technologies, Inc. | POpen-market purchase Series A Cumulative Convertible Preferred Stockderivativeindirect: See footnote | +122 | $1,000.00 | $122k | 305 | Feb 15, 2024 |
| May 16, 2023 | SHWZ Medicine Man Technologies, Inc. | POpen-market purchase Series A Cumulative Convertible Preferred Stockderivativeindirect: See footnote | +140 | $1,000.00 | $140k | 445 | Feb 15, 2024 |
Questions about Justin Dye
Answered from the filings on this page, as of the latest one.
Is Justin Dye buying or selling?
Justin Dye has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Justin Dye's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Justin Dye has 0.
Where does Justin Dye file Form 4?
Justin Dye has filed Form 4 at SHWZ (Medicine Man Technologies, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.